# A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults

> **NCT02562144** · PHASE4 · COMPLETED · sponsor: **Isala** · enrollment: 17 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Xylocaine spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02562144
- **Lead sponsor:** Isala
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-05
- **Primary completion:** 2016-04-06
- **Final completion:** 2016-04-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562144, "A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02562144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*